A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment
NCT07187297
This study is recruiting at 7 US sites in 5 states, according to its ClinicalTrials.gov record last updated .
Summary
A prospective, 180-day, randomized, multicenter, independent blinded evaluators, controlled study of treatment with the Thermage FLX System
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Wrinkle
- Lax Skin
- Lines Skin
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 30 to 60 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Bausch Health Americas, Inc.
- Last updated on ClinicalTrials.gov
- August 26, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 3
- Laser & Skin Surgery Center of Northern California · Sacramento, CA
- Cosmetic Laser Dermatology · San Diego, CA
- Cosmetic Laser Dermatology · San Diego, CA
Illinois · 1
- Chicago Cosmetic Surgery and Dermatology · Chicago, IL
Massachusetts · 1
- SkinCare Physicians · Chestnut Hill, MA
New York · 1
- Union Square Laser Dermatology · New York, NY
Texas · 1
- Dermatology and Laser Surgery Center · Houston, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.